Press release content from PR Newswire. The AP news staff was not involved in its creation. Grifols Extends Commitment to World Federation of Hemophilia Humanitarian Aid Program to 2030 April 15, 2021 GMT BARCELONA, Spain, April 15, 2021 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global leader in the development of plasma-derived medicines with a track record of more than 100 years dedicated to enhancing people’s health and well-being, today announced that it will donate a minimum of 240 million international units (IU) of blood clotting factor medicines (Factor VIII and Factor IX) to the World Federation of Hemophilia (WFH) Humanitarian Aid Program over the next eight years, from 2022 to 2030.